FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: ValueSet/2.16.840.1.113883.3.1444.3.194

Packageus.nlm.vsac
Resource TypeValueSet
Id2.16.840.1.113883.3.1444.3.194
FHIR VersionR4
Sourcehttp://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.1444.3.194/expansion
URLhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.194
Version20250409
Statusactive
Date2025-04-09T01:09:28-04:00
NameTrastuzumabInjectable
TitleTrastuzumab Injectable
Realmus
Authorityhl7
Purpose(Clinical Focus: The purpose of this value set is to represent concepts of medication Trastuzumab.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication Trastuzumab and biosimilars; generic; prescribable; injectable.),(Exclusion Criteria: Excludes trastuzumab emtansine.)

Resources that use this resource

ValueSet
2.16.840.1.113883.3.1444.5.229Minimal Emetic Risk Intravenous Antineoplastic Agent

Resources that this resource uses

CodeSystem
rxnormRxNorm

Narrative

No narrative content found in resource


Source

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.1444.3.194",
  "meta": {
    "versionId": "25",
    "lastUpdated": "2025-04-09T01:09:28.000-04:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "American Society of Clinical Oncology Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2025-04-09"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2025-04-09"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.194",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113883.3.1444.3.194"
    }
  ],
  "version": "20250409",
  "name": "TrastuzumabInjectable",
  "title": "Trastuzumab Injectable",
  "status": "active",
  "date": "2025-04-09T01:09:28-04:00",
  "publisher": "American Society of Clinical Oncology Steward",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: The purpose of this value set is to represent concepts of medication Trastuzumab.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication Trastuzumab and biosimilars; generic; prescribable; injectable.),(Exclusion Criteria: Excludes trastuzumab emtansine.)",
  "compose": {
    "include": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "concept": [
          {
            "code": "1922509",
            "display": "trastuzumab 150 MG Injection"
          },
          {
            "code": "2107053",
            "display": "trastuzumab-pkrb 21 MG/ML Injectable Solution"
          },
          {
            "code": "2119714",
            "display": "5 ML hyaluronidase-oysk 2000 UNT/ML / trastuzumab-oysk 120 MG/ML Injection"
          },
          {
            "code": "2169359",
            "display": "trastuzumab-pkrb 150 MG Injection"
          },
          {
            "code": "2174804",
            "display": "trastuzumab-anns 21 MG/ML Injectable Solution"
          },
          {
            "code": "2179753",
            "display": "trastuzumab-dkst 150 MG Injection"
          },
          {
            "code": "2179760",
            "display": "trastuzumab-dkst 21 MG/ML Injectable Solution"
          },
          {
            "code": "2257297",
            "display": "trastuzumab-anns 150 MG Injection"
          },
          {
            "code": "2280732",
            "display": "trastuzumab-qyyp 21 MG/ML Injectable Solution"
          },
          {
            "code": "2289227",
            "display": "trastuzumab-dttb 150 MG Injection"
          },
          {
            "code": "2289234",
            "display": "trastuzumab-dttb 21 MG/ML Injectable Solution"
          },
          {
            "code": "2472791",
            "display": "trastuzumab-qyyp 150 MG Injection"
          }
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:f2759c8f-68c9-4004-b394-8e1daf1767c4",
    "timestamp": "2025-05-23T21:54:28-04:00",
    "total": 12,
    "contains": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1922509",
        "display": "trastuzumab 150 MG Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2107053",
        "display": "trastuzumab-pkrb 21 MG/ML Injectable Solution"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2119714",
        "display": "5 ML hyaluronidase-oysk 2000 UNT/ML / trastuzumab-oysk 120 MG/ML Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2169359",
        "display": "trastuzumab-pkrb 150 MG Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2174804",
        "display": "trastuzumab-anns 21 MG/ML Injectable Solution"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2179753",
        "display": "trastuzumab-dkst 150 MG Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2179760",
        "display": "trastuzumab-dkst 21 MG/ML Injectable Solution"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2257297",
        "display": "trastuzumab-anns 150 MG Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2280732",
        "display": "trastuzumab-qyyp 21 MG/ML Injectable Solution"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2289227",
        "display": "trastuzumab-dttb 150 MG Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2289234",
        "display": "trastuzumab-dttb 21 MG/ML Injectable Solution"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2472791",
        "display": "trastuzumab-qyyp 150 MG Injection"
      }
    ]
  }
}